Cytosorbents (CTSO) Tops Q1 EPS by 3c

Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.15), $0.03 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $5.2 million versus the consensus estimate of $6.17 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Wolfe upgrades AT&T to Outperform as improving fundamentals outweigh Starlink risk
• Heritage Financial (HFWA) Tops Q2 EPS by 12c
• Old Second Bancorp (OSBC) Misses Q2 EPS by 1c